what's better for weight loss semaglutide or tirzepatide vs. Semaglutide vs Tirzepatide for Weight

GLP-1 medications reshape appetite control by acting on brain hunger centers, making portion sizes feel naturally smaller

Semaglutide (Ozempic and Rybelsus) makes us less hungry and interested in food, contributing to gradual weight loss.

The GLP-1 receptor agonist semaglutide reduces risks of kidney function loss, kidney failure, cardiovascular events, cardiovascular death and all-cause mortality in people with CKD and T2DM Ongoing clinical and mechanistic studies are expected to expand use of GLP-1 receptor agonists, GLP-1/GIP and other metabolic hormones for the treatment of CKD At the moment the most complete data is available for semaglutide from SUSTAIN-6 and FLOW trial which is the only trial with primary renal outcome in T2DM patients out of all GLP-1 RA Very good data for renal outcomes as secondary ones available for GLP-1 RAs dulaglutide and liraglutide and GLP-1/GIP RA tirzepatide, Very interesting and positive data from mechanistic REMODEL trial with semaglutide in T2DM patients presented but not yet published (reduced perirenal fat, rernal fibrosis and much more) Based on following excellent papers: #glp1 #gip #semaglutide #tirzepatide #liraglutide #dulaglutide #kidney #ckd #chronickidneydisease #cardiovascularcomplications

Bu, kan ekeri seviyelerinin dzenlenmesinde hayati roller oynayan iki hormon olan GLP1 (glukagon benzeri peptid 1) ve GIP'nin (gastrik inhibitr polipeptid) etkisini taklit eden sentetik bir peptiddir

For complicated cases of Interstitial Cystitis, urodynamics testing may be recommended